CHI Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

CHI Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,000	Closed	-$954K	–	24
2020 Q3	$954K	Sell	7,000 -6,500	-48%	-$691K	0.34%	15
2020 Q2	$1.3M	Sell	13,500 -1,500	-10%	-$125K	0.51%	10
2020 Q1	$703K	Buy	15,000 +5,000	+50%	+$320K	1.66%	10
2019 Q4	$729K	Sell	10,000 -12,464	-55%	-$756K	0.55%	9
2019 Q3	$1.17M	Buy	+22,464	New	+$1.19M	1.14%	8

CHI Advisors's MYOK Position: Q4 2020 in Review

CHI Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 7,000 shares — an estimated $954K sold.

CHI Advisors first reported a position in MYOK in Q3 2019 and held it in 5 quarters. The position peaked at $1.3M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

CHI Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
CHI Advisors sold 7,000 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $954K.
CHI Advisors first reported a position in MyoKardia, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
CHI Advisors's MyoKardia, Inc. Common Stock position peaked at $1.3M in Q2 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on CHI Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.